Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray Crystal Structure Data in the Optimisation of P3 and P4 Substituents
Andrews, D.M., Chaignot, H., Coomber, B.A., Good, A.C., Hind, S.L., Johnson, M.R., Jones, P.S., Mill, G., Robinson, J.E., Skarzynski, T., Slater, M.J., Somers, D.O.N.(2002) Org Lett 4: 4479-4482
- PubMed: 12465917 
- DOI: https://doi.org/10.1021/ol027014p
- Primary Citation of Related Structures:  
1N1L - PubMed Abstract: 
[reaction: see text] In this, the second of two letters, we describe the elaboration of the pyrrolidine-5,5-trans-lactam template to delineate the requirements for optimal substitution of the pyrrolidine and lactam nitrogen atoms. Central to the strategy is the use of rapid iterative synthesis in conjunction with X-ray crystal structure determination of ligand-protein complexes.
Organizational Affiliation: 
GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, UK. david.m.andrews@gsk.com